CTOs on the Move

SpineGuard

www.spineguard.com

 
Founded in 2009 in France and the USA by Pierre Jerome and Stephane Bette, SpineGuard is an innovative company deploying its proprietary radiation-free real time sensing technology DSG® (Dynamic Surgical Guidance) to secure and streamline the placement of implants in the skeleton. SpineGuard designs, develops and markets medical devices that have been used in over 80,000 surgical procedures worldwide. Sixteen studies published in peer-reviewed scientific journals have demonstrated the multiple benefits DSG® offers to patients, surgeons, surgical staff and hospitals. Building on these solid fundamentals and several strategic partnerships, SpineGuard has expanded its technology platform in a disruptive innovation: the ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.spineguard.com
  • 1434 Spruce Street Suite 100
    Boulder, CO USA 80302
  • Phone: 720.726.8085

Executives

Name Title Contact Details

Similar Companies

Mevex

Mevex is a Stittsville, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Body Vision Medical

Body Vision Medical is an early commercial stage medical device company specialising in augmented real-time imaging, artificial intelligence and intra-body navigation.

Power Medical Interventions

Power Medical Interventions, Inc is a Mansfield, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

IOMED

IOMED is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Median Technologies

Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. As The Imaging Phenomics Company®, Median provides insights into novel therapies and treatment strategies. Our unique solutions, MediScan® for lesion management in patient care, Lesion Management Solution (LMS) for lesion detection, measurement and reporting in clinical trials, and our imaging phenotyping system iBiopsy®, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy. Median Technologies supports biopharmaceutical sponsors and healthcare professionals around the world in bringing new and targeted treatments to patients in need with an eye on reducing overall costs. This is how we are helping to create a healthier world. Founded in 2002, based in Sophia-Antipolis, France, with a US subsidiary in Boston, Median has received the label “Innovative company” by the BPI and is listed on Euronext Paris` Alternext market (ISIN: FR0011049824, ticker: ALMDT). The company is eligible for the PEA-PME SME equity savings plan setup and has received the label Pass French Tech Promotion 2016-2017.